CARISMA Therapeutics
Latest round
- Series B
Last raised
- Dec 2020
Total raised
- $97M
Investors
- 14
About CARISMA Therapeutics
Based in the US, CARISMA Therapeutics Inc.CARISMA Therapeutics Inc. is dedicated to creating novel cancer therapies through its CAR-M technology. Founded in 2016, the company is headquartered in Philadelphia, US. The founders, Michael Klichinsky and Saar Gill, have backgrounds that include involvement in other biotechnology ventures.CARISMA Therapeutics offers a unique range of therapeutic products that leverage its CAR-M platform, aiming to overcome challenges in cancer treatment. These innovative therapies are designed specifically for addressing various cancer types, targeting healthcare providers and institutions seeking advanced treatment options.CARISMA Therapeutics generates revenue through strategic partnerships with healthcare providers and institutions for its therapeutic solutions. The revenue model is structured around cooperative agreements and licensing arrangements, facilitating sustained income from collaborative research and development projects.Looking ahead, CARISMA Therapeutics plans to expand its product offerings with new therapies expected to be launched in the next 18 months, enhancing its CAR-M platform capabilities. The company is also targeting expansion into European markets, aiming to establish operations by the end of 2024.00 mn will support these initiatives, allowing for increased research and development efforts, as well as strategic marketing to penetrate new regions effectively.
Who invested in CARISMA Therapeutics
14 investors across 4 rounds
See all investors in CARISMA Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CARISMA Therapeutics
Who invested in CARISMA Therapeutics?
CARISMA Therapeutics has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CARISMA Therapeutics raised?
CARISMA Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did CARISMA Therapeutics last raise money?
CARISMA Therapeutics's most recent round on record is a Series B, in Dec 2020.
What does CARISMA Therapeutics do?
Based in the US, CARISMA Therapeutics Inc.
Where is CARISMA Therapeutics headquartered?
CARISMA Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like CARISMA Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CARISMA Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CARISMA Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.